POSTN and myotonic dystrophy type 1: Combined with the finding that Postn was significantly upregulated in skeletal muscle of DM1 patients, these results suggest that targeting extracellular POSTN – for example, using neutralizing antibodies – is a potential approach for treating muscle wasting in DM1.